Accessibility/Mobile Features
Skip Navigation
Skip to Content
Editorial News
Lifestyles
Classified Sites

The Canadian Press - ONLINE EDITION

Study: Cheap chemo drug greatly boosts survival for men with advanced prostate cancer

CHICAGO - A cheap, decades-old chemotherapy drug extended life by more than a year when added to standard hormone therapy for men whose prostate cancer has widely spread, doctors reported Sunday.

Men who received docetaxel, sold as Taxotere and in generic form, lived nearly 58 months versus 44 months for those not given the drug, a major study found.

"This is one of the biggest improvements we've seen in survival in adults" with any type of cancer that has widely spread from its original site, said Dr. Christopher Sweeney of Dana-Farber Cancer Institute in Boston. He led the study and shared the results Sunday at the American Society of Clinical Oncology's annual conference in Chicago.

Prostate cancer is the most common cancer in men. In the United States, about 240,000 new cases are diagnosed each year. About 30,000 annually are like the men in this study, with disease that has spread to bones or other organs.

In the study, all 790 men received drugs to block testosterone, a hormone that fuels prostate cancer's growth, and half also were given six infusions of docetaxel, one every three weeks.

About 2 1/2 years later, 101 of the men given docetaxel had died versus 136 of the men who did not receive it. One man died from the treatment, and about 6 per cent had fevers from low blood counts, but most were able to tolerate treatment well, Sweeney said.

The National Cancer Institute paid for the study, which took nearly a decade to do. The result shows the importance of federal funding for research that otherwise might not get done, said Dr. Clifford Hudis, who works at Memorial Sloan Kettering Cancer Center in New York and also is the president of the oncology society.

"These are often studies that industry is less interested in funding, such as a new use for an old drug" that lost patent protection long ago, he said.

Generic docetaxel costs about $1,500 or less per infusion. That's far less than some other cancer drugs, which can exceed $100,000 for a course of treatment.

___

Online:

Cancer info: http://www.cancer.net and http://tinyurl.com/o5p6ahb

___

Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP

  • Rate this Rate This Star Icon
  • This article has not yet been rated.
  • We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high. If you thought it was well written, do the same. If it doesn’t meet your standards, mark it accordingly.

    You can also register and/or login to the site and join the conversation by leaving a comment.

    Rate it yourself by rolling over the stars and clicking when you reach your desired rating. We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high.

Sort by: Newest to Oldest | Oldest to Newest | Most Popular 0 Commentscomment icon

You can comment on most stories on brandonsun.com. You can also agree or disagree with other comments. All you need to do is register and/or login and you can join the conversation and give your feedback.

There are no comments at the moment. Be the first to post a comment below.

Post Your Commentcomment icon

Comment
  • You have characters left

The Brandon Sun does not necessarily endorse any of the views posted. Comments are moderated before publication. By submitting your comment, you agree to our Terms and Conditions. New to commenting? Check out our Frequently Asked Questions.

letters

Make text: Larger | Smaller

Brandon Sun Business Directory
The First World War at 100
Why Not Minot?
Welcome to Winnipeg

Social Media